Pinnacle Associates’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.15M Sell
114,268
-29,107
-20% -$1.06M 0.06% 265
2025
Q1
$5.19M Sell
143,375
-5,118
-3% -$185K 0.08% 233
2024
Q4
$6.25M Buy
148,493
+29,133
+24% +$1.23M 0.08% 211
2024
Q3
$5.71M Sell
119,360
-41,660
-26% -$1.99M 0.1% 222
2024
Q2
$6.62M Buy
161,020
+41,633
+35% +$1.71M 0.1% 202
2024
Q1
$5.57M Buy
119,387
+27
+0% +$1.26K 0.09% 234
2023
Q4
$5.71M Buy
119,360
+5
+0% +$239 0.1% 225
2023
Q3
$4.26M Sell
119,355
-3,841
-3% -$137K 0.08% 244
2023
Q2
$5.68M Sell
123,196
-3,201
-3% -$148K 0.1% 217
2023
Q1
$5.07M Sell
126,397
-2,039
-2% -$81.8K 0.1% 205
2022
Q4
$5.95M Sell
128,436
-1,982
-2% -$91.8K 0.13% 183
2022
Q3
$5.4M Sell
130,418
-3,640
-3% -$151K 0.12% 193
2022
Q2
$8M Sell
134,058
-2,221
-2% -$133K 0.17% 147
2022
Q1
$9.9M Sell
136,279
-5,295
-4% -$385K 0.18% 150
2021
Q4
$11.9M Sell
141,574
-782
-0.5% -$65.8K 0.21% 132
2021
Q3
$12.8M Sell
142,356
-4,159
-3% -$375K 0.24% 119
2021
Q2
$14M Buy
146,515
+1,225
+0.8% +$117K 0.25% 115
2021
Q1
$16.5M Sell
145,290
-13,065
-8% -$1.49M 0.32% 92
2020
Q4
$21.9M Sell
158,355
-9,331
-6% -$1.29M 0.45% 66
2020
Q3
$13.8M Sell
167,686
-6,513
-4% -$535K 0.33% 85
2020
Q2
$13.6M Sell
174,199
-4,572
-3% -$358K 0.34% 85
2020
Q1
$7.94M Sell
178,771
-33,616
-16% -$1.49M 0.24% 116
2019
Q4
$9.07M Buy
212,387
+139,380
+191% +$5.95M 0.2% 137
2019
Q3
$3.12M Buy
+73,007
New +$3.12M 0.07% 249